Change search criteria ↓

Search results

22 projects found matching your search criteria:

  1. 1. Design of high selective and safe juvenile hormone epoxide hydrolases inhibitors targeting selected pests based on the c…

    Principal investigator: dr hab. Artur Wiktor Góra

    Politechnika Śląska, Centrum Biotechnologii

    Call: OPUS 20, Panel: ST4

  2. 2. Organometallic compounds as selective inhibitors of selected multidrug resistance proteins

    Principal investigator: dr hab. Damian Nestor Plażuk

    Uniwersytet Łódzki, Wydział Chemii

    Call: OPUS 15, Panel: ST5

  3. 3. Effect of SSR 504734, a selective glycine transporter type 1 inhibitor, on seizure activity and therapeutic efficacy of …

    Principal investigator: prof. Piotr Wiktor Wlaź

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

    Call: OPUS 21, Panel: NZ7

  4. 4. Effect of therapy with selective serotonin reuptake inhibitors and physical exercise on blood brain barrier permeability…

    Principal investigator: Marta Anna Małkiewicz

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej

    Call: PRELUDIUM 17, Panel: NZ5

  5. 5. Impact of combined therapy of non-steroidal anti-inflammatory drugs and selective serotonin reuptake inhibitors on oxida…

    Principal investigator: dr hab. Piotr Gałecki

    Uniwersytet Medyczny w Łodzi, Wydział Wojskowo-Lekarski; Klinika Psychiatrii Dorosłych

    Call: OPUS 3, Panel: NZ5

  6. 6. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha…

    Principal investigator: dr Dawid Marcin Panek

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  7. 7. Identification of key structural elements of immunomodulatory proteins - inhibitors of antigenic peptide transporter TAP…

    Principal investigator: dr Natalia Anna Karska

    Uniwersytet Gdański, Wydział Chemii

    Call: SONATA 18, Panel: NZ7

  8. 8. The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on changes in selected epigenetic mechan…

    Principal investigator: Agnieszka Magdalena Woźniak

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 21, Panel: NZ7

  9. 9. 7,8-disubstituted theophylline derivatives that are potent inhibitors of selected PDE isoenzymes as a new compounds with…

    Principal investigator: dr Katarzyna Anna Wójcik-Pszczoła

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 14, Panel: NZ7

  10. 10. Analysis of selected physicochemical, biological and pharmacological properties of biomedical materials modified by synt…

    Principal investigator: dr Katarzyna Szałapata

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

    Call: PRELUDIUM 8, Panel: NZ7

  11. 11. Studies on the influence of selected inhibitors of kinases involved in signaling pathways in tumor cells on NK cell cyto…

    Principal investigator: Marta Siernicka

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

    Call: PRELUDIUM 7, Panel: NZ6

  12. 12. Design and synthesis of selective and irreversible inhibitors of HAT protease.

    Principal investigator: Marcin Skoreński

    Politechnika Wrocławska, Wydział Chemiczny

    Call: PRELUDIUM 5, Panel: ST5

  13. 13. Cellular mechanisms and effects in vivo of selective lactate dehydrogenase A inhibitors in experimental models of mesoth…

    Principal investigator: prof. Ryszard Tomasz Smoleński

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 16, Panel: NZ7

  14. 14. The influence of perinatal exposure to selective serotonin reuptake inhibitors on the structure and functions of mice do…

    Principal investigator: prof. Grzegorz Władysław Hess

    Instytut Farmakologii PAN

    Call: OPUS 14, Panel: NZ4

  15. 15. The active center and beyond: towards new selective inhibitors of S-adenosyl-L-homocysteine hydrolase. Structural enzymo…

    Principal investigator: dr Krzysztof Brzeziński

    Uniwersytet w Białymstoku, Wydział Biologiczno-Chemiczny

    Call: OPUS 5, Panel: NZ1

  16. 16. 3D structure-based search for selective inhibitor of thymidylate synthase of nematodes, a potential drug in chemotherapy…

    Principal investigator: prof. Wojciech Krzysztof Rode

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 1, Panel: NZ6

  17. 17. Selective inhibition of Janus kinases for the treatment of autoimmune hepatitis: Translational PK/PD modelling from mole…

    Principal investigator: dr Artur Świerczek

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 19, Panel: NZ7

  18. 18. SELECTIVE REGULATION OF RAB GTPASES BY TARGETING PROTEIN-PROTEIN INTERACTIONS BETWEEN RABS AND REGULATORY PROTEINS

    Principal investigator: dr hab. Katarzyna Magdalena Błażewska

    Politechnika Łódzka, Wydział Chemiczny

    Call: PRELUDIUM BIS 3, Panel: ST4

  19. 19. Search for structure-antimicrobial activity correlation for selected boraheterocycles

    Principal investigator: prof. Sergiusz Mariusz Luliński

    Politechnika Warszawska, Wydział Chemiczny

    Call: OPUS 16, Panel: ST5

  20. 20. Synthesis and study of anticancer activities and affinities to kinesin of selected sandwich and half-sandwich organometa…

    Principal investigator: dr hab. Damian Nestor Plażuk

    Uniwersytet Łódzki, Wydział Chemii

    Call: OPUS 9, Panel: ST5

  21. 21. Understanding the contribution of immunoproteasome activation to the neuropathic pain development.

    Principal investigator: dr Natalia Eleonora Małek-Chudzik

    Politechnika Wrocławska

    Call: OPUS 25, Panel: NZ7

  22. 22. The use of evolutionary patterns in the optimization of chemotherapy of tuberculosis

    Principal investigator: dr Alina Ewa Minias

    Instytut Biologii Medycznej PAN

    Call: SONATA BIS 9, Panel: NZ6

Graphic design and implementation: Jakub Piotrowski